It's a 'dangerous' time to bet against whipping-boy stocks - Goldman Sachs' Pasquariello
Source: SeekingAlpha
2025-10-16 11:17:03 ET
More on the markets:
- Chair Powell's New Revelations On Monetary Policy
- Small Caps Don't Make All-Time Highs On The Cusp Of A Downturn
- 5 Trend Indicators For Deciding If The Bull Market Is Breaking Down
- U.S. stocks add to gains as more corporate earnings lift sentiment amid government shutdown
- Wall Street gains as traders assess more corporate earnings; U.S. government shutdown drags on
Read the full article on Seeking Alpha
For further details see:
It's a 'dangerous' time to bet against whipping-boy stocks – Goldman Sachs’ Pasquariello
CytomX Therapeutics Inc.
NASDAQ: CTMX
CTMX Trading
-1.58% G/L:
$4.675 Last:
1,737,279 Volume:
$4.90 Open:
CTMX Latest News
March 04, 2026 08:00:00 am
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
CTMX Stock Data
$945,449,504
141,817,426
0.97%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
